Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 30;18(6):2139123.
doi: 10.1080/21645515.2022.2139123. Epub 2022 Nov 15.

A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult population

Bai Yunhua  1 , Bai Peng  2 , Li Shuping  1 , Zhang Zheng  1
Affiliations
Review

A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult population

Bai Yunhua et al. Hum Vaccin Immunother. .

Abstract

The 23-valent pneumococcal polysaccharide vaccine (PPSV-23) is the only approved vaccine for pneumococcal diseases in elderly Chinese population. Though regional studies explored the PPSV-23 vaccination coverage rates and influencing factors in China, a large-scale, nation-wide epidemiological surveillance studies to understand the different factors impeding pneumococcal vaccination rate are required. Hence, this review summarized PPSV-23 coverage rate, analyzed and identified vaccination influencing factors among elderly population across China by exploring articles published in CNKI, Wanfang and PubMed databases. Pneumococcal vaccination coverage rate was found to be low at around 1.23%~42.10% in China. Co-morbidities, knowledge, attitude, perception toward pneumonia and PPSV-23, education level, socio-economic disparities, health education and local policies were some of the factors associated with vaccination willingness among elderly Chinese population. Interventions or policies like government funding, subsidies, inclusion of PPSV-23 in medical insurance, or systematic encouragement from HCPs as key strategies should be implemented to encourage vaccination.

Keywords: 23-valent pneumococcal polysaccharide vaccine; China; PPSV-23; elderly population; pneumococcal vaccine; pneumonia; willingness.

PubMed Disclaimer

Conflict of interest statement

Peng Bai is employee of MSD China; all other authors have none to declare.

Figures

Figure 1.
Figure 1.
Vaccination rate of PPSV-23 among elderly population from different regions of China.
Figure 2.
Figure 2.
Different cities have implemented city immunization program (CIP) in China for providing people over 60 years old with a free pneumococcal vaccination (PPSV-23). In 2019, 16% of overall released doses were covered under CIP.
See this image and copyright information in PMC

References

    1. Chen Q, Wang L, Xie M, Li X, Recommendations for Influenza, Streptococcus pneumoniae Vaccination in Elderly People in China Writing Group, Geriatric Respiratory Group and Chinese Society of Geriatrics . Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China. Aging Med. 2020;3(1):4–8. doi:10.1002/agm2.12102. - DOI - PMC - PubMed
    1. Drijkoningen JJC, Rohde GGU.. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014;20:45–51. doi:10.1111/1469-0691.12461. - DOI - PubMed
    1. Zhou M, Zhan J, Kong N, Campy KS, Chen Y. Factors associated with intention to uptake pneumococcal vaccines among Chinese elderly aged 60 years and older during the early stage of COVID-19 pandemic. Psychol Health Med. 2022;27(1):91–105. doi:10.1080/13548506.2021.1905862. - DOI - PubMed
    1. Li Y, Lv Y, Xue F, Zhang XZ, Hu XJ, Yu T. Antimicrobial susceptibility surveillance of gram-positive bacteria from ministry of health national antimicrobial resistance investigation net (Mohnarin) 2011-2012. Chin J Clin Pharm. 2014;30:251–60.
    1. Qin Y, Yu H. Chinese prevention medicine association. [Technical guideline on application of pneumococcal vaccine in China (2012)]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33:1101–10. - PubMed

Substances